These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 208328)

  • 41. Newcastle Disease Virus-Based Vectored Vaccine against Poliomyelitis.
    Viktorova EG; Khattar SK; Kouiavskaia D; Laassri M; Zagorodnyaya T; Dragunsky E; Samal S; Chumakov K; Belov GA
    J Virol; 2018 Sep; 92(17):. PubMed ID: 29925653
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Lessons from Cuba: mass campaign administration of trivalent oral poliovirus vaccine and seroprevalence of poliovirus neutralizing antibodies.
    Mas Lago P; Ramon Bravo J; Andrus JK; Comellas MM; Galindo MA; de Quadros CA; Bell E
    Bull World Health Organ; 1994; 72(2):221-5. PubMed ID: 8205641
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Kinetics of antibody response by Dot-ELISA in rabbits immunized with adult Haemonchus contortus antigen.
    Kaur K; Kapur J; Parmar A; Sood ML
    Parasite; 2002 Dec; 9(4):363-5. PubMed ID: 12514952
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cellular and humoral immune responses to poliovirus in mice: a role for helper T cells in heterotypic immunity to poliovirus.
    Katrak K; Mahon BP; Minor PD; Mills KH
    J Gen Virol; 1991 May; 72 ( Pt 5)():1093-8. PubMed ID: 1851808
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Modified radial-plaque-neutralization test for demonstration of enterovirus neutralizing antibodies.
    Nagy G; Takátsy S
    Arch Virol; 1980; 65(2):89-98. PubMed ID: 6252870
    [TBL] [Abstract][Full Text] [Related]  

  • 46. An evaluation of several adjuvant emulsion regimens for the production of polyclonal antisera in rabbits.
    Johnston BA; Eisen H; Fry D
    Lab Anim Sci; 1991 Jan; 41(1):15-21. PubMed ID: 1849580
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Biphenyl-exposed rabbits.
    Koller LD; Thigpen JE
    Am J Vet Res; 1973 Dec; 34(12):1605-6. PubMed ID: 4202752
    [No Abstract]   [Full Text] [Related]  

  • 48. Protection against radiation leukemogenesis by repeated injections of immune and nonimmune foreign sera.
    Ferrer JF; Lieberman M; Kaplan HS
    Cancer Res; 1973 Jun; 33(6):1339-43. PubMed ID: 4352370
    [No Abstract]   [Full Text] [Related]  

  • 49. Antibody response of children immunized with poliovaccines: an evaluation using two strains of poliovirus type 1.
    Deshpande JM; Dave KH
    Indian J Med Res; 1992 Sep; 95():216-20. PubMed ID: 1335965
    [TBL] [Abstract][Full Text] [Related]  

  • 50. How to predict the immune status of poliovirus vaccinees? A comparison of virus neutralization at a very low serum dilution versus ELISA in a cohort of infants.
    Simhon A; Lifshitz A; Abed Y; Lasch EE; Schoub B; Morag A
    Int J Epidemiol; 1990 Mar; 19(1):164-8. PubMed ID: 2161806
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [A monoclonal antibody panel for the intratypic differentiation of type-2 polioviruses].
    Shyrobokov VP; Nikolaienko IV; Kopanytsia LV; Solohub VK; Ivanova OIe
    Mikrobiol Z; 1997; 59(6):27-36. PubMed ID: 9511373
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Neutralization kinetics of poliovirus by specific antiserum during the course of immunization of rabbits.
    Ozaki Y
    Arch Gesamte Virusforsch; 1968; 25(2):137-47. PubMed ID: 4303671
    [No Abstract]   [Full Text] [Related]  

  • 53. Binding of tracer FSH, LH, GH, and TSH by anti-FSH sera prepared by several immunization regimens.
    Nixon WE; Cargille CM
    J Lab Clin Med; 1971 Dec; 78(6):949-56. PubMed ID: 5131858
    [No Abstract]   [Full Text] [Related]  

  • 54. [Status of immunity against poliomyelitis. Polio serosurvey in 1993].
    Diedrich S; Schreier E
    Dtsch Med Wochenschr; 1995 Feb; 120(8):239-44. PubMed ID: 7867480
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Fluorescent antibody study of a new bovine herpesvirus (strain DN-599).
    Sass B; Mohanty SB; Hetrick FM
    Am J Vet Res; 1974 Oct; 35(10):1343-6. PubMed ID: 4371526
    [No Abstract]   [Full Text] [Related]  

  • 56. Immunological and pathogenic properties of poliovirus variants selected for resistance to antiviral drug V-073.
    Kouiavskaia DV; Dragunsky EM; Liu HM; Oberste MS; Collett MS; Chumakov KM
    Antivir Ther; 2011; 16(7):999-1004. PubMed ID: 22024515
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antigen chimaeras of poliovirus as potential new vaccines.
    Burke KL; Dunn G; Ferguson M; Minor PD; Almond JW
    Nature; 1988 Mar; 332(6159):81-2. PubMed ID: 2450279
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Monitoring of poliovirus neutralizing antibodies in São Paulo State, Brazil.
    Luchs A; Cilli A; Russo DH; Costa FF; Carmona Rde C; Timenetsky Mdo C
    Trans R Soc Trop Med Hyg; 2010 Sep; 104(9):625-7. PubMed ID: 20708125
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Complement-fixation test for detection of viral antibodies in chicken serum. I. Standardization of the test for detection of antibodies to Newcastle disease virus and polyoma virus.
    Wilcox GE; Consigli RA
    Avian Dis; 1972; 16(5):1011-8. PubMed ID: 4344859
    [No Abstract]   [Full Text] [Related]  

  • 60. Freund's adjuvants: their influence on the specificity of viral antisera.
    Jorgensen PE
    Acta Pathol Microbiol Scand B Microbiol Immunol; 1972; 80(6):931-3. PubMed ID: 4509399
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.